Boulder Hill Capital Management LP Iveric Bio, Inc. Transaction History

Boulder Hill Capital Management LP

  • $47.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$9.12 - $18.9 $165,984 - $343,980
18,200 New
18,200 $175,000
Q1 2022

May 12, 2022
SELL
$12.15 - $16.83 $252,720 - $350,063
-20,800 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$13.83 - $18.78 $287,664 - $390,624
20,800 New
20,800 $348,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Boulder Hill Capital Management LP Portfolio

Follow Boulder Hill Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boulder Hill Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Boulder Hill Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email